Disseminated intravascular coagulation in sepsis

S Zeerleder, CE Hack, WA Wuillemin - Chest, 2005 - Elsevier
Disseminated intravascular coagulation is a frequent complication of sepsis. Coagulation
activation, inhibition of fibrinolysis, and consumption of coagulation inhibitors lead to a …

C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema

C Caliezi, WA Wuillemin, S Zeerleder, M Redondo… - Pharmacological …, 2000 - ASPET
C1-esterase inhibitor (C1-Inh) therapy was introduced in clinical medicine about 25 years ago
as a replacement therapy for patients with hereditary angioedema caused by a deficiency …

VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism

…, PS Wells, M Rodger, WA Wuillemin… - Thrombosis and …, 2009 - thieme-connect.com
Clinical outcome studies have shown that it is safe to withhold anticoagulant therapy in patients
with suspected pulmonary embolism (PE) who have a negative D-dimer result and a low …

[PDF][PDF] Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo

…, S Hammerschmidt, W Müller-Esterl, WA Wuillemin… - Immunity, 2011 - cell.com
Activated mast cells trigger edema in allergic and inflammatory disease. We report a paracrine
mechanism by which mast cell-released heparin increases vascular permeability in vivo. …

Elevated nucleosome levels in systemic inflammation and sepsis

S Zeerleder, B Zwart, WA Wuillemin… - Critical care …, 2003 - journals.lww.com
… Zeerleder, Sacha MD; Zwart, Bas MD; Wuillemin, Walter A. MD, PhD; Aarden, Lucien A.
PhD; Groeneveld, AB Johan MD; Caliezi, Christoph MD; van Nieuwenhuijze, Annemarie EM; …

Thromboembolism and bleeding tendency in congenital factor XII deficiency-a study on 74 subjects from 14 Swiss families

B Lämmle, WA Wuillemin, I Huber… - Thrombosis and …, 1991 - thieme-connect.com
… The dysfunctional F XII molecule (F XII Washington DC) of one of these individuals has been
purified and partially charactenzed by Saito and Scialla (43), and the postulated defect near …

Association of two silent polymorphisms of platelet glycoprotein la/lla receptor with risk of myocardial infarction: a case-control study

K Moshfegh, WA Wuillemin, M Redondo, B Lämmle… - The Lancet, 1999 - thelancet.com
… Walter Wuillemin and Maurice Redondo were responsible for patient data and blood
collection and did the statistical analysis. The paper was mainly written by Beat Meyer, but all …

[HTML][HTML] ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock

…, H Ten Cate, PH Reitsma, WA Wuillemin… - Journal of Thrombosis …, 2007 - Elsevier
… TEN CATE 6 7 , PH REITSMA 6 , WA WUILLEMIN 8 , B. LÄMMLE 1 … Lämmle and WA
Wuillemin. S. Zeerleder and WA Wuillemin recruited patients and collected clinical data. JA Kremer …

Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy

…, M Redondo, F Julmy, WA Wuillemin… - Journal of the American …, 2000 - jacc.org
OBJECTIVES We sought to compare the inhibitory effects of the combination of two doses of
aspirin plus clopidogrel with either drug alone on platelet aggregation and activation. …

Rivaroxaban: quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories

…, B Seifert, H Stricker, DA Tsakiris, WA Wuillemin - Thrombosis research, 2012 - Elsevier
INTRODUCTION: Rivaroxaban (RXA) is licensed for prophylaxis of venous thromboembolism
after major orthopaedic surgery of the lower limbs. Currently, no test to quantify RXA in …